Patients with thrombolysed stroke in Vietnam have an excellent outcome: Results from the Vietnam Thrombolysis Registry

European Journal of Neurology

Volumn 17, Issue 9, 2010, Pages 1188-1192

  Nguyen, T H ^a   Truong, A L T ^a   Ngo, M B ^a   Bui, C T Q ^a   Dinh, Q V ^a   Doan, T C ^a   Nguyen, L T K ^a   Phan, T C ^b   Phan, M V ^b   Nguyen, T V ^c   Le, T V ^a  

^a People's Hospital 115   (Viet Nam)

^b Department of Neurology   (Viet Nam)

^c An Binh Hospital   (Viet Nam)

Author keywords

Acute stroke therapy; Intracerebral hemorrahage; Ischaemic stroke; rtPA; Thrombolysis; tPA

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; SYSTOLIC BLOOD PRESSURE; VIET NAM;

ADOLESCENT; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VIETNAM; YOUNG ADULT;

EID: 77955811518     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.02995.x     Document Type: Article

References (12)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995 333 : 1581 1587.
2. Adams HP Jr., Adams RJ, Brott T, et al. Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003 34 : 1056 1083.
3. Ueshima S, Matsuo O. The differences in thrombolytic effects of administrated recombinant t-PA between Japanese and Caucasians. Thromb Haemost 2002 87 : 544 546.
4. Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993 24 : 35 41.
5. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 363 : 768 774.
6. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST): an observational study. Lancet 2007 369 : 275 282.
7. Suwanwela NC, Phanthumchinda K, Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: the first prospective evaluation. Clin Neurol Neurosurg 2006 108 : 549 552.
8. Padma MV, Singh MB, Bhatia R, et al. Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India 2007 55 : 46 49.
9. Sharma VK, sivgoulis GT, Tan JH, et al. Feasibility and Safety of Intravenous Thrombolysis in Multiethnic Asian Stroke Patients in Singapore. J Stroke Cerebrovasc Dis 2010 in press.
10. Yamaguchi T, Mori E, Minematsu K, et al. Alteplase at 0.6 mgkg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006 37 : 1810 1815.
11. Hill MD, Buchan AM Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005 172 : 1307 1312.
12. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP, et al. Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Pooled Analysis of Randomized Clinical Trials. Stroke 2005 36 : 62 65. (Pubitemid 40054176)